Enzolytics Inc.
OTC:ENZC
Overview | Financials
Company Name | Enzolytics Inc. |
Symbol | ENZC |
Currency | USD |
Price | 0.022 |
Market Cap | 53,065,461 |
Dividend Yield | 0% |
52-week-range | 0.016 - 0.132 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Charles S. Cotropia |
Website | https://enzolytics.com |
An error occurred while fetching data.
About Enzolytics Inc.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD